Omnicell (OMCL)
(Delayed Data from NSDQ)
$27.47 USD
-0.22 (-0.79%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $27.49 +0.02 (0.07%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Industry / Sector Report
Industry : Medical Info Systems
Zacks Industry Rank
Top 34% (88 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.50 | 1.72 | 9.99 |
Current Quarter Estimate | 0.12 | -0.31 | 59.00 |
Year Ago Quarter Estimate | 0.39 | 0.01 | 50.37 |
Next Quarter Estimate | 0.30 | -0.11 | 60.00 |
Next Year Estimate | 1.39 | 0.11 | 238.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -43.46 | 18.80 | 20.73 |
Next Year | 30.56 | 28.90 | 13.55 |
Last 5 Years | -6.10 | -10.70 | 9.00 |
Next 5 Years | NA | 20.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 14.50 | -19.27 |
Price/Book (MRQ) | 1.06 | 1.33 |
Price/Cash Flow (MRFY) | 8.81 | 9.39 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1.78% | -42.70% |
Return on Equity (TTM) | 3.43% | -23.58% |
Debt to Equity (MRQ) | 0.48 | 8.59 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.